Drug Detail

Drug Name Lenalidomide
Trade Name Revlimid
Synonyms IMiD-1
Drug Descriptions

Revlimid (lenalidomide) inhibits angiogenesis and promotes G1 cell cycle arrest and apoptosis of malignant cells. It is a thalidomide analog which inhibits TNF-alpha production, stimulates T cells, and reduces serum levels of the cytokines VEGF and bFGF (NCI Drug Dictionary).

DrugClasses

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Therapy Description
Carfilzomib + Dexamethasone + Elotuzumab + Lenalidomide
Ibrutinib + lenalidomide
lenalidomide + Sonidegib
Dexamethasone + Lenalidomide + Venetoclax
Bortezomib + Dexamethasone + Isatuximab + Lenalidomide
Ipilimumab + lenalidomide
lenalidomide + Fludarabine + Melphalan
AMG 232 + Carfilzomib + Dexamethasone + lenalidomide
Ibrutinib + Lenalidomide + Obinutuzumab + Prednisone + Venetoclax
Cyclophosphamide + Dexamethasone + Lenalidomide
Lenalidomide + Rituximab + Romidepsin
Lenalidomide + MOR208
Bortezomib + Dexamethasone + Lenalidomide
Dexamethasone + Lenalidomide + PAT-SM6
Ixazomib + Lenalidomide + Rituximab
Temsirolimus + Lenalidomide
Atezolizumab + lenalidomide + Obinutuzumab
Dexamethasone + Isatuximab + Lenalidomide
Lenalidomide + Ofatumumab
lenalidomide + Obinutuzumab + Polatuzumab Vedotin
lenalidomide + MEDI4736
Dexamethasone + lenalidomide + Pembrolizumab
Elotuzumab + Dexamethasone + Lenalidomide
Carfilzomib + Dexamethasone + Lenalidomide
lenalidomide + Pembrolizumab
Dexamethasone + Ixazomib + Lenalidomide
Methylprednisolone + Lenalidomide + Ruxolitinib
R2-ICE
Cetuximab + lenalidomide
Bortezomib + Elotuzumab + Dexamethasone + lenalidomide
Nivolumab + Lenalidomide + Dexamethasone
Carfilzomib + Dexamethasone + lenalidomide + Panobinostat
lenalidomide + Pidilizumab
Lenalidomide + Sorafenib
Rituximab + Lenalidomide + Ibrutinib
Dexamethasone + Lenalidomide + LGH447
BEAM + Lenalidomide + Filgrastim + Rituximab
Lenalidomide + Nivolumab
Lenalidomide + PAT-SM6
Cediranib + Lenalidomide
ACY-1215 + Dexamethasone + lenalidomide
Lenalidomide
MEDI4736 + R2-CHOP
Elotuzumab + lenalidomide
Lenalidomide + SJB3-019A
Dasatinib + lenalidomide
lenalidomide + MEDI4736 + Rituximab
Dexamethasone + lenalidomide + Ulocuplumab
Lenalidomide + TAK-659
Bortezomib + Cyclophosphamide + lenalidomide
Lenalidomide + Rituximab + Venetoclax Revlimid (lenalidomide) inhibits angiogenesis and promotes G1 cell cycle arrest and apoptosis of malignant cells. It is a thalidomide analog which inhibits TNF-alpha production, stimulates T cells, and reduces serum levels of the cytokines VEGF and bFGF (NCI Drug Dictionary).
Dexamethasone + Lenalidomide
Dexamethasone + GSK2857916 + Lenalidomide
Ibrutinib + Lenalidomide + Dexamethasone
Lenalidomide + Obinutuzumab
Bortezomib + Daratumumab + Dexamethasone + Lenalidomide
PVX-410 + MEDI4736 + lenalidomide
Lenalidomide + Vorinostat
Lenalidomide + Nivolumab + Rituximab
Acalabrutinib + Lenalidomide + Rituximab Calquence (acalabrutinib) selectively inhibits BTK, resulting in decreased B-cell receptor signaling, and potentially leading to decreased tumor cell proliferation (PMID: 27903679, PMID: 26957112). Calquence (acalabrutinib) is FDA approved for use in patients with mantle cell lymphoma (FDA.gov).
Lenalidomide + Obinutuzumab + Venetoclax
Bortezomib + lenalidomide
Bortezomib + Lenalidomide + PAT-SM6
Bortezomib + Dexamethasone + lenalidomide + Panobinostat
Daratumumab + Dexamethasone + Lenalidomide
Lenalidomide + PVX-410
Lenalidomide + Rituximab + Thalidomide